We were very pleased to see the article on the impact of migraines on workplace productivity.
However, we noticed a small error at the end regarding the source. The study in question was not part of a specific Topamax study program and was non-branded. Ortho-McNeil Neurologics sponsored the study, and markets the FDA-approved product, Topamax, for migraine prevention.
It is a small error, but we felt obliged to ensure the correct information was provided.
Thank you and best regards,
Ortho-McNeil Neurologics Communications